Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epclusa in adults with chronic hepatitis C on dialysis for end-stage renal disease
MOH_2017-09-17_000679Phase 2Active, not recruiting
- Sponsor
- Gilead Sciences
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of velpatasvir in hepatitis C virus infection, sponsored by Gilead Sciences. Started Sep 2017; status: active, not recruiting.
02
Drugs
velpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on MOH_2017-09-17_000679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-09-17_000679.